AAAAAA

   
Results: 1-6 |
Results: 6

Authors: King, J McLeod, J Gonsette, RE Duquette, P Ebers, G Rice, G Francis, G Lapierre, Y Freedman, MS Oger, J Paty, D Sorensen, PS Pelletier, J Hommes, OR Jongen, PJH Sanders, EACM Andersen, O Wollheim-Sandberg, M Chofflon, M Bates, D Barnes, D Blumhardt, LD Hawkins, C Hughes, RAC Palace, J Newsom-Davis, JM Young, CA Ammoury, N Bacchi, M Francis, G Galazka, A Hyde, R Shah, S
Citation: J. King et al., Randomized controlled trial of interferon-beta-1a in secondary progressiveMS - Clinical results, NEUROLOGY, 56(11), 2001, pp. 1496-1504

Authors: Hintzen, RQ Pot, K Paty, D Oger, J
Citation: Rq. Hintzen et al., Analysis of effector CD4 (OX-40(+)) and CD8 (CD45RA(+) CD27(-)) T lymphocytes in active multiple sclerosis, ACT NEUR SC, 101(1), 2000, pp. 57-60

Authors: Fischer, JS LaRocca, NG Miller, DM Ritvo, PG Andrews, H Paty, D
Citation: Js. Fischer et al., Recent developments in the assessment of quality of life in Multiple Sclerosis (MS), MULT SCLER, 5(4), 1999, pp. 251-259

Authors: Ebers, G Lee, D Rice, G Lesaux, J Kennedy, K Sanders, EACM Versteylen, RJ van Andel, JD Story, JP de Milliano, M O'Connor, P Cheung, G Houston, P Hall, J Comi, G Filippi, M Martinelli, V Santuccio, G Poggi, A Gironi, M Moiola, L Duquette, P Bourgouin, P Pepin, G Poirer, J Bernier, G Dubois, R Metz, L Diamond, RT Bell, R McGowan, D Demchuk, A Harris, E Yeung, M Murphy, A Murray, TJ Vandorpe, R Bhan, V Maxner, C Weldon, P Armstrong, L Bouchard, JP Grondin, P Gosselin, F Thibaut, M Kirouac, L Morin, A Abramsky, O Gomori, JM Karussis, D Karni, A Mor, M Freedman, MS Avruch, L Nelson, R Christie, S Rabinovitch, H Freedman, C Benavente, M Pelletier, J Levrier, O Bensa, P Dalesky, A Paty, D Li, D Rhodes, B Riddehough, A Zhao, G Wang, X Chang, Y Abdul-Ahad, A Ammoury, N Dupont, F Francis, G Furcha, R Galazka, A Hyde, R Olson, M Pernin, MO Shah, S Freedman, M Ebers, G Murray, J O'Connor, P Paty, D Rice, G Francis, G
Citation: G. Ebers et al., Evidence of interferon beta-1a dose response in relapsing-remitting MS - The OWIMS study, NEUROLOGY, 53(4), 1999, pp. 679-686

Authors: Rice, GPA Paszner, B Oger, J Lesaux, J Paty, D Ebers, G
Citation: Gpa. Rice et al., The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon beta-1b, NEUROLOGY, 52(6), 1999, pp. 1277-1279

Authors: Hintzen, RQ Paty, D Oger, J
Citation: Rq. Hintzen et al., Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis, J NE NE PSY, 66(6), 1999, pp. 791-793
Risultati: 1-6 |